Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza
Clinical trial NCT03682120 · COMPLETED
Trial details
- NCT number
- NCT03682120
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-02
- Primary completion
- 2020-04-30
- Enrollment
- 372
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.